Matches in Wikidata for { <http://www.wikidata.org/entity/Q101052587> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q101052587 description "2020 ވަނަ އަހަރުގެ އޮކްޓޯބަރުމަހުގެ 19ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ލިޔުމެއް" @default.
- Q101052587 description "artículu científicu espublizáu n'ochobre de 2020" @default.
- Q101052587 description "scientific article published on 19 October 2020" @default.
- Q101052587 description "wetenschappelijk artikel" @default.
- Q101052587 description "наукова стаття, опублікована 19 жовтня 2020" @default.
- Q101052587 name "FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer" @default.
- Q101052587 name "FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer" @default.
- Q101052587 name "FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer" @default.
- Q101052587 type Item @default.
- Q101052587 label "FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer" @default.
- Q101052587 label "FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer" @default.
- Q101052587 label "FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer" @default.
- Q101052587 prefLabel "FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer" @default.
- Q101052587 prefLabel "FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer" @default.
- Q101052587 prefLabel "FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer" @default.
- Q101052587 P1433 Q101052587-0EDC3B91-B888-424F-97EE-89A4253B631C @default.
- Q101052587 P1476 Q101052587-3B1F24F0-CE9D-425F-B47B-7C38BF282F90 @default.
- Q101052587 P2093 Q101052587-33996CB7-E167-49DC-AF61-39BBF4B9DC2B @default.
- Q101052587 P2093 Q101052587-6A12CD99-6C4B-4D3B-8DD3-7774B260EF08 @default.
- Q101052587 P2093 Q101052587-9AB648D9-181A-4544-99AD-55B553A07C41 @default.
- Q101052587 P2093 Q101052587-C5CE49C9-CC92-425F-BBD1-22BE4B48E42E @default.
- Q101052587 P275 Q101052587-1878eb91-a7f5-4a31-a25c-a6192a50f08f @default.
- Q101052587 P304 Q101052587-7320A9DD-52E1-4DF6-A719-6FEF4667C02D @default.
- Q101052587 P31 Q101052587-35712254-463A-4215-A145-2139F1404448 @default.
- Q101052587 P356 Q101052587-DA9012B1-CA26-4E58-8979-E3E035DF32F6 @default.
- Q101052587 P478 Q101052587-ECC6A323-5824-43E1-85A5-1545E987640D @default.
- Q101052587 P50 Q101052587-A52EC6DB-2F47-4BEA-B8E9-A7D2215A18B1 @default.
- Q101052587 P577 Q101052587-3FD246C9-B308-4201-A257-5B7258D1C1B1 @default.
- Q101052587 P6216 Q101052587-a350b81e-d3e6-4eb1-bcf1-719eb7a8dcc0 @default.
- Q101052587 P698 Q101052587-5DB33012-9486-4418-A9C8-14ECEC7EF8A0 @default.
- Q101052587 P921 Q101052587-2A6F0A6C-555D-402A-86E5-187FF9C81CD7 @default.
- Q101052587 P932 Q101052587-BCB7DEE9-005B-48BE-8222-2265DE62BF89 @default.
- Q101052587 P356 CMAR.S267393 @default.
- Q101052587 P698 33116881 @default.
- Q101052587 P1433 Q5031417 @default.
- Q101052587 P1476 "FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer" @default.
- Q101052587 P2093 "Martina Catalano" @default.
- Q101052587 P2093 "Monica Ramello" @default.
- Q101052587 P2093 "Raffaele Conca" @default.
- Q101052587 P2093 "Roberto Petrioli" @default.
- Q101052587 P275 Q18810331 @default.
- Q101052587 P304 "10271-10278" @default.
- Q101052587 P31 Q13442814 @default.
- Q101052587 P356 "10.2147/CMAR.S267393" @default.
- Q101052587 P478 "12" @default.
- Q101052587 P50 Q41428812 @default.
- Q101052587 P577 "2020-10-19T00:00:00Z" @default.
- Q101052587 P6216 Q50423863 @default.
- Q101052587 P698 "33116881" @default.
- Q101052587 P921 Q212961 @default.
- Q101052587 P932 "7585276" @default.